Neostigmine is used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is sold under the brand name Bloxiverz. Reference standards of Neostigmine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Neostigmine bromide (N0500000) [catalogue_number] => PA EPN0500000 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => neostigmine-bromide-n0500000-paepn0500000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPN0500000
CAS :
Molecular Formula : NA
Molecular Weight : NA
stdClass Object ( [pname] => Neostigmine metilsulfate (N0550000) [catalogue_number] => PA EPN0550000 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => neostigmine-metilsulfate-n0550000-paepn0550000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPN0550000
stdClass Object ( [pname] => Neostigmine impurity A (Y0001639) [catalogue_number] => PA EPY0001639 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => neostigmine-impurity-a-y0001639-paepy0001639 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPY0001639
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
